Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetics and Clinical Response of Tolvaptan in Neurocritical Care Patients

NCT02215148 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.

NCT NCT02215148
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02215148 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetics and Clinical Response of Tolvaptan in Neurocritical Care Patients
Lead sponsor
University of North Carolina, Chapel Hill
Phase
Observational
Overall status
Terminated
Start date
November 30, 2014
Completion date
August 31, 2016
Enrollment
1 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

brain injury, hyponatremia